Capsular Distension Versus Corticosteroid Injection in Adhesive Capsulitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFaculty of Medicine of Tunis

About this trial

Adhesive capsulitis is a common and disabling shoulder condition characterized by pain and progressive limitation of range of motion. Capsular distension and intra-articular corticosteroid injection are commonly used therapeutic options, often combined with rehabilitation, but their comparative effectiveness remains debated.

The objective of this randomized controlled trial is to compare the efficacy and tolerance of ultrasound-guided capsular distension combined with rehabilitation versus intra-articular corticosteroid injection combined with rehabilitation in patients with adhesive capsulitis.

Outcomes will include shoulder pain, range of motion, functional disability, patient satisfaction, and procedure-related complications, assessed at short, mid, and long-term follow-up.

Eligibility criteria

Qualifiers

Age between 18 and 80 years

Ability to provide informed consent

Shoulder pain with Visual Analog Scale (VAS) ≥ 40/100

Limitation of external rotation < 45° or < 50% compared to the contralateral side

Disqualifiers

Rotator cuff tear

Previous shoulder surgery

Cervico-brachial neuralgia

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • capsular distension
  • Betamethasone (Diprostene®) Injection

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators